Brief: Cipher Pharmaceuticals announces approvals of SD Cream and AD Cream
06/04/2016 21:00
April 6 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher Pharmaceuticals announces approvals of astion
acquired barrier creams by Health Canada and the Medicines
Evaluation Board
* Says in addition European approval of helioclin pruritus
SD cream (also known as pruridexin) was achieved
* In Canada , Cipher plans to market products through its
internal sales team
* Says company expects to out-license helioclin pruritus sd
cream and helioclin dermatitis SD cream in Europe
Source text for Eikon: ID:nCNWkpHFLa
Further company coverage: CPH.TO
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million